×
About 159 results

ALLMedicine™ Anaplastic Oligoastrocytoma Center

Research & Reviews  79 results

Successful treatment of a BRAF V600E-mutant extracranial metastatic anaplastic oligoast...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422448
Cancer Biology & Therapy; Shi L, Zou Z et. al.

Nov 21st, 2018 - Extracranial metastasis is a rare phenomenon of anaplastic oligoastrocytoma. When patients progress after comprehensive treatment, there is often no effective treatment. Rapid development of gene detection technology makes precision treatment of g...

Possibility of venoarterial extracorporeal membranous oxygenator being a bridging thera...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155969
Medicine Iwashita Y, Hiramoto T et. al.

Sep 14th, 2018 - Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare but lethal complication of carcinoma, defined as non-occlusive pulmonary tumor embolism complicated by fibrocellular intimal proliferation of the small pulmonary arteries, with eventual o...

SEOM clinical guidelines for anaplastic gliomas (2017).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785606
Clinical & Translational Oncology : Official Publication ... Balañá C, Alonso M et. al.

Oct 23rd, 2017 - The SEOM/GEINO clinical guidelines provide recommendations for radiological, and molecular diagnosis, treatment and follow-up of adult patients with anaplastic gliomas (AG). We followed the 2016 WHO classification which specifies the major diagnos...

Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas.
https://doi.org/10.1017/cjn.2016.420
The Canadian Journal of Neurological Sciences. Le Journal... McNamara MG, Jiang H et. al.

May 10th, 2017 - Radiotherapy with procarbazine, lomustine, and vincristine improves overall survival (OS) in patients with 1p19q co-deleted anaplastic oligodendroglioma/anaplastic oligoastrocytoma. This retrospective analysis investigated outcomes in patients wit...

Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologo...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596171
Neuro-oncology Thomas AA, Abrey LE et. al.

May 4th, 2017 - Anaplastic oligodendroglioma (AO) and anaplastic oligoastrocytoma (AOA) are chemotherapy-sensitive tumors with prolonged survival after radiochemotherapy. We report a prospective trial using induction temozolomide (TMZ) followed by myeloablative h...

see more →

Guidelines  1 results

SEOM clinical guidelines for anaplastic gliomas (2017).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785606
Clinical & Translational Oncology : Official Publication ... Balañá C, Alonso M et. al.

Oct 23rd, 2017 - The SEOM/GEINO clinical guidelines provide recommendations for radiological, and molecular diagnosis, treatment and follow-up of adult patients with anaplastic gliomas (AG). We followed the 2016 WHO classification which specifies the major diagnos...

see more →

Clinicaltrials.gov  79 results

Successful treatment of a BRAF V600E-mutant extracranial metastatic anaplastic oligoast...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422448
Cancer Biology & Therapy; Shi L, Zou Z et. al.

Nov 21st, 2018 - Extracranial metastasis is a rare phenomenon of anaplastic oligoastrocytoma. When patients progress after comprehensive treatment, there is often no effective treatment. Rapid development of gene detection technology makes precision treatment of g...

Possibility of venoarterial extracorporeal membranous oxygenator being a bridging thera...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155969
Medicine Iwashita Y, Hiramoto T et. al.

Sep 14th, 2018 - Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare but lethal complication of carcinoma, defined as non-occlusive pulmonary tumor embolism complicated by fibrocellular intimal proliferation of the small pulmonary arteries, with eventual o...

SEOM clinical guidelines for anaplastic gliomas (2017).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785606
Clinical & Translational Oncology : Official Publication ... Balañá C, Alonso M et. al.

Oct 23rd, 2017 - The SEOM/GEINO clinical guidelines provide recommendations for radiological, and molecular diagnosis, treatment and follow-up of adult patients with anaplastic gliomas (AG). We followed the 2016 WHO classification which specifies the major diagnos...

Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas.
https://doi.org/10.1017/cjn.2016.420
The Canadian Journal of Neurological Sciences. Le Journal... McNamara MG, Jiang H et. al.

May 10th, 2017 - Radiotherapy with procarbazine, lomustine, and vincristine improves overall survival (OS) in patients with 1p19q co-deleted anaplastic oligodendroglioma/anaplastic oligoastrocytoma. This retrospective analysis investigated outcomes in patients wit...

Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologo...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596171
Neuro-oncology Thomas AA, Abrey LE et. al.

May 4th, 2017 - Anaplastic oligodendroglioma (AO) and anaplastic oligoastrocytoma (AOA) are chemotherapy-sensitive tumors with prolonged survival after radiochemotherapy. We report a prospective trial using induction temozolomide (TMZ) followed by myeloablative h...

see more →